- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on CNS Vasculitis in Switzerland
Total 188 results
-
Claudio GobbiSwiss Multiple Sclerosis SocietyCompletedMultiple SclerosisSwitzerland
-
Klinik ValensGerman Sport University, CologneCompletedMultiple SclerosisSwitzerland
-
Klinik ValensKU Leuven; Mindmaze SACompletedStroke | Multiple Sclerosis | Balance DisordersSwitzerland
-
University Hospital HeidelbergGerman Cancer Research CenterRecruitingSolid Tumor | CNS TumorFrance, Germany, Australia, Austria, Sweden, Netherlands, Switzerland
-
University Hospital, Basel, SwitzerlandNovartis Pharma AG, Basel, SwitzerlandCompletedMultiple Sclerosis (MS)Switzerland
-
Chiara ZeccaWithdrawn
-
University Hospital Inselspital, BernePharmaPart; Viollier AG, Basel, SwitzerlandCompletedRelapsing-remitting Multiple SclerosisSwitzerland
-
University Hospital Inselspital, BerneCompleted
-
University Hospital, GenevaOncovir, Inc.; Immatics Biotechnologies GmbHCompletedCNS Tumor, AdultSwitzerland
-
University Hospital, Basel, SwitzerlandActive, not recruitingMultiple SclerosisSwitzerland
-
Jochen VehoffCompletedMultiple Sclerosis | Autonomic Nervous System DysfunctionSwitzerland
-
University Hospital, Basel, SwitzerlandSwiss Multiple Sclerosis Society; Bangerter-Rhyner Stiftung; Center for Chronic...Active, not recruitingMultiple SclerosisSwitzerland
-
Sebastian WolfUniversity of BernCompletedMacular Edema | CNVSwitzerland
-
Human Genome Sciences Inc., a GSK CompanyGlaxoSmithKlineCompletedVasculitisUnited States, Australia, France, Spain, Italy, Peru, Belgium, Canada, Germany, Romania, Mexico, United Kingdom, Hungary, Ireland, Poland, Switzerland, Czechia, Russian Federation, Norway, Sweden
-
Klinik ValensGerman Sport University, Cologne; University of Applied Sciences and Arts of...CompletedMultiple SclerosisSwitzerland
-
Claudio GobbiOspedale Civico, LuganoCompletedRelapsing-remitting Multiple SclerosisSwitzerland
-
Claudio GobbiBayerTerminatedRelapsing-remitting Multiple SclerosisSwitzerland
-
Cantonal Hospital of St. GallenUnknownRelapsing-Remitting Multiple SclerosisSwitzerland
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Clinical Isolated Syndrome (CIS)Czech Republic, Switzerland
-
Prof Patrice LaliveRecruitingZoster | ShinglesSwitzerland
-
Klinik ValensRecruitingMultiple Sclerosis, Chronic Progressive | High-Intensity Interval Training | Motor SymptomsSwitzerland
-
Cantonal Hospital of St. GallenBayerUnknownMultiple Sclerosis | Cognitive ImpairmentSwitzerland
-
Chiara ZeccaABREOCCompletedMultiple Sclerosis, Relapsing-RemittingSwitzerland
-
Swiss Federal Institute of TechnologyKliniken Valens, Rehazentrum Valens, Taminaplatz 1, 7317 ValensCompletedAssessment of Arm and Hand Sensorimotor Functions in Multiple Sclerosis SubjectsSwitzerland
-
Zurich University of Applied SciencesSwiss National Science FoundationCompleted
-
Brigitte SchürchCentre Hospitalier Universitaire VaudoisRecruitingMultiple Sclerosis | Urinary Bladder, NeurogenicSwitzerland
-
Luzerner KantonsspitalRecruitingStroke | Multiple Sclerosis | Parkinson DiseaseSwitzerland
-
University of ZurichSwiss National Science FoundationRecruitingMultiple Sclerosis | Training | Spinal Cord Injuries | Gait Disorders, Neurologic | NeurorehabilitationSwitzerland
-
University of ZurichSwiss National Science Foundation; Swiss Paraplegic Research, NottwilRecruitingSpinal Cord Injuries | Gait Disorders, NeurologicSwitzerland
-
Cantonal Hospital of St. GallenBiogenUnknownMultiple Sclerosis | Cognitive ImpairmentSwitzerland
-
Insel Gruppe AG, University Hospital BernRecruitingMultiple Sclerosis | Fatigue | HypogammaglobulinemiaSwitzerland
-
Klinik ValensTechnische Universität Dortmund, GermanyRecruitingExercise | Cardiorespiratory Fitness | Primary Progressive Multiple SclerosisSwitzerland
-
BiogenCompleted
-
InflaRx GmbHCompletedGranulomatosis With Polyangiitis (GPA) | Microscopic Polyangiitis (MPA)Germany, Russian Federation, Belgium, France, Spain, Czechia, Italy, Netherlands, Sweden, Switzerland, United Kingdom
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
Cantonal Hospital of St. GallenCompletedIntussusception | Rectocele | Obstructed Defecation Syndrome | SNSSwitzerland
-
Novartis PharmaceuticalsRecruitingGiant Cell Arteritis | Polymyalgia RheumaticaUnited States, Spain, Switzerland, Portugal
-
University of ZurichUniversity Hospital, Geneva; University of Bern; Swiss Tropical & Public Health... and other collaboratorsCompletedArthritis, Rheumatoid | Vasculitis | SpondylarthritisSwitzerland
-
University of California, San FranciscoActive, not recruitingMultiple Sclerosis | Cognitive DeclineUnited States, Switzerland
-
University of ZurichSwiss National Science Foundation; Balgrist University HospitalCompletedMultiple Sclerosis | Overactive Bladder | Spinal Cord Injury | Neurogenic Lower Urinary Tract DysfunctionSwitzerland
-
BiogenRecruitingMultiple SclerosisSpain, Switzerland, Ireland, United States, Germany
-
AmgenCompletedAdvanced Non CNS TumorsUnited States, Belgium, Spain, France, Canada, Italy, Switzerland
-
Swiss Federal Institute of TechnologyUniversity of ZurichTerminated
-
University Hospital, Basel, SwitzerlandRecruitingMultiple Sclerosis, Relapsing-RemittingSwitzerland
-
Casa Sollievo della Sofferenza IRCCSNeurocenter of Southern Switzerland; Associazione Revert ONLUS; Fondazione Cellule...CompletedSecondary-progressive Multiple SclerosisItaly, Switzerland
-
University Hospital, Basel, SwitzerlandUniversity Hospital, Geneva; University of Lausanne Hospitals; National Multiple... and other collaboratorsRecruiting
-
Clinique Romande de ReadaptationCompletedStroke | Multiple Sclerosis | Cerebral Palsy | Parkinson Disease | Spinal Cord Injuries | People With Impaired Lower Extremity FunctionSwitzerland
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple Sclerosis RRMSGermany, Switzerland
-
Novartis PharmaceuticalsTerminatedSecondary Progressive Multiple Sclerosis With Inflammatory Disease ActivitySwitzerland